[HTML][HTML] Treatment of EBV-related post-renal transplant lymphoproliferative disease with a tailored regimen including EBV-specific T cells
P Comoli, R Maccario, F Locatelli, U Valente… - American Journal of …, 2005 - Elsevier
The treatment of EBV-associated post-transplant lymphoproliferative disease (PTLD) poses
a considerable challenge. Efforts have been made to define regimens based on
combination of the available therapeutic agents, chosen and tailored on a patient-by-patient
basis, with the aim of augmenting event-free patient and graft survival. Recently, autologous
EBV-specific cytotoxic T-lymphocytes (CTL) have proved effective in enhancing EBV-specific
immune responses and reducing viral load in organ transplant recipients with active …
a considerable challenge. Efforts have been made to define regimens based on
combination of the available therapeutic agents, chosen and tailored on a patient-by-patient
basis, with the aim of augmenting event-free patient and graft survival. Recently, autologous
EBV-specific cytotoxic T-lymphocytes (CTL) have proved effective in enhancing EBV-specific
immune responses and reducing viral load in organ transplant recipients with active …